Regencell Bioscience Holdings Ltd (RGC) Balance Sheet
As of 2026-06-30 (20-F), Regencell Bioscience Holdings Ltd (RGC) reported total assets of $14.7M, total liabilities of $1.4M and shareholders' equity of $13.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $14.2M.
Source: SEC EDGAR filings · read by EquiReason
RGCRegencell Bioscience Holdings LtdFollow RGC — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.4 | 0.1 | 6.4 | 1.6 | 3.0 | 2.4 | 14.2 | 14.2 | |
| Short-term investments | — | — | 10.0 | 10.0 | 5.0 | 2.5 | — | — | |
| Current assets | 0.4 | 0.1 | 16.4 | 11.6 | 8.1 | 4.9 | 14.2 | 14.2 | |
| Total assets | 0.5 | 0.3 | 18.0 | 12.6 | 8.4 | 5.8 | 14.7 | 14.7 | |
| Current liabilities | 3.2 | 4.3 | 0.6 | 0.6 | 0.2 | 0.7 | 1.3 | 1.3 | |
| Short-term debt | — | 3.3 | — | — | — | — | — | — | |
| Total liabilities | 3.2 | 4.3 | 0.9 | 0.6 | 0.2 | 0.9 | 1.4 | 1.4 | |
| Shareholders' equity | -2.7 | -4.0 | 17.1 | 12.0 | 8.2 | 4.9 | 13.3 | 13.3 |
USD millions · SEC XBRL
Regencell Bioscience Holdings Ltd — questions
- How much cash does Regencell Bioscience Holdings Ltd have?
- $14.2M in cash and cash equivalents as of 2026-06-30.
- What are Regencell Bioscience Holdings Ltd's total assets?
- $14.7M as of 2026-06-30.
- What is Regencell Bioscience Holdings Ltd's shareholders' equity?
- $13.3M as of 2026-06-30.
Every figure on this page comes from Regencell Bioscience Holdings Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.